(R)-adrenaline increases activity EXP 6480464 Epinephrine results in increased activity of ADRA2A protein CTD PMID:17341653 (R)-adrenaline multiple interactions ISO Adra2a (Mus musculus) 6480464 Epinephrine promotes the reaction [GNB2 protein binds to ADRA2A protein] more ... CTD PMID:30737458 (R)-adrenaline multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [Epinephrine binds to and results in increased activity of ADRA2A protein] which results in increased abundance of Calcium more ... CTD PMID:17680988 and PMID:20030735 (R)-noradrenaline affects secretion EXP 6480464 ADRA2A protein affects the secretion of Norepinephrine CTD PMID:11312645 (R)-noradrenaline multiple interactions ISO Adra2a (Mus musculus) 6480464 [ADRA2A protein mutant form co-treated with ADRA2C protein mutant form] results in increased abundance of Norepinephrine CTD PMID:20083574 (R)-noradrenaline affects abundance ISO Adra2a (Mus musculus) 6480464 ADRA2A protein affects the abundance of Norepinephrine CTD PMID:20083574 (R)-noradrenaline multiple interactions ISO ADRA2A (Homo sapiens) 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:10742289 and PMID:20030735 (R)-noradrenaline affects binding ISO Adra2a (Mus musculus) 6480464 Norepinephrine binds to ADRA2A protein CTD PMID:10336518 (R)-noradrenaline multiple interactions EXP 6480464 [BRL 44408 binds to and results in decreased activity of ADRA2A protein] inhibits the reaction [Xylazine inhibits the reaction [Potassium results in increased secretion of Norepinephrine]] CTD PMID:11312645 1,2-dimethylhydrazine multiple interactions ISO Adra2a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ADRA2A mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO Adra2a (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of ADRA2A mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO Adra2a (Mus musculus) 6480464 Estradiol results in increased expression of ADRA2A mRNA CTD PMID:15713686 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO ADRA2A (Homo sapiens) 6480464 2 more ... CTD PMID:19095052 2,3,4,7,8-Pentachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADRA2A mRNA CTD PMID:21724226 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ADRA2A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Adra2a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ADRA2A mRNA CTD PMID:26377647 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:21724226 2-methoxyidazoxan affects binding ISO ADRA2A (Homo sapiens) 6480464 ADRA2A protein binds to 2-methoxyidazoxan CTD PMID:20030735 2-methoxyidazoxan multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Epinephrine inhibits the reaction [ADRA2A protein binds to 2-methoxyidazoxan] more ... CTD PMID:20030735 2-phenylethylamine affects binding ISO ADRA2A (Homo sapiens) 6480464 phenethylamine binds to ADRA2A protein CTD PMID:20217639 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADRA2A mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADRA2A mRNA CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to ADRA2A promoter] CTD PMID:20348232 3-methylcholanthrene multiple interactions ISO Adra2a (Mus musculus) 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ADRA2A mRNA CTD PMID:23519560 4,4'-sulfonyldiphenol increases expression ISO Adra2a (Mus musculus) 6480464 bisphenol S results in increased expression of ADRA2A mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine increases expression ISO ADRA2A (Homo sapiens) 6480464 Decitabine results in increased expression of ADRA2A mRNA CTD PMID:19194470 5-aza-2'-deoxycytidine affects expression ISO ADRA2A (Homo sapiens) 6480464 Decitabine affects the expression of ADRA2A mRNA CTD PMID:17145863 8-Br-cAMP decreases expression ISO ADRA2A (Homo sapiens) 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ADRA2A mRNA CTD PMID:22079614 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of ADRA2A mRNA CTD PMID:28959563 acrylamide decreases expression ISO ADRA2A (Homo sapiens) 6480464 Acrylamide results in decreased expression of ADRA2A mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO Adra2a (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of ADRA2A mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO ADRA2A (Homo sapiens) 6480464 Tretinoin results in increased expression of ADRA2A mRNA CTD PMID:21934132 amiodarone increases expression ISO ADRA2A (Homo sapiens) 6480464 Amiodarone results in increased expression of ADRA2A mRNA CTD PMID:19774075 amitraz multiple interactions EXP 6480464 [Idazoxan binds to and results in decreased activity of ADRA2A protein] which results in decreased susceptibility to amitraz and amitraz binds to and results in increased activity of ADRA2A protein CTD PMID:10582558 amitraz decreases activity ISO ADRA2A (Homo sapiens) 6480464 amitraz results in decreased activity of ADRA2A protein CTD PMID:21251949 amphotericin B decreases expression ISO ADRA2A (Homo sapiens) 6480464 Amphotericin B analog results in decreased expression of ADRA2A mRNA CTD PMID:28534445 aristolochic acid A increases expression ISO ADRA2A (Homo sapiens) 6480464 aristolochic acid I results in increased expression of ADRA2A mRNA CTD PMID:33212167 arsenous acid decreases expression ISO ADRA2A (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of ADRA2A mRNA CTD PMID:26705709 atenolol affects response to substance ISO ADRA2A (Homo sapiens) 6480464 ADRA2A gene SNP affects the susceptibility to Atenolol CTD PMID:15614026 atrazine affects activity EXP 6480464 Atrazine affects the activity of ADRA2A protein CTD PMID:11071396 atrazine increases expression ISO ADRA2A (Homo sapiens) 6480464 Atrazine results in increased expression of ADRA2A mRNA CTD PMID:22378314 atrazine affects binding EXP 6480464 Atrazine binds to ADRA2A protein CTD PMID:11071396 benzalkonium chloride multiple interactions ISO Adra2a (Mus musculus) 6480464 [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of ADRA2A mRNA CTD PMID:30171875 benzo[a]pyrene decreases expression ISO Adra2a (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of ADRA2A mRNA CTD PMID:19770486 benzo[a]pyrene increases methylation ISO ADRA2A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of ADRA2A 5' UTR and Benzo(a)pyrene results in increased methylation of ADRA2A promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Adra2a (Mus musculus) 6480464 Benzo(a)pyrene promotes the reaction [AHR protein binds to ADRA2A promoter] CTD PMID:19654925 bisphenol A decreases expression ISO ADRA2A (Homo sapiens) 6480464 bisphenol A results in decreased expression of ADRA2A mRNA CTD PMID:33476716 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ADRA2A mRNA CTD PMID:30816183 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ADRA2A mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADRA2A mRNA CTD PMID:28628672 bisphenol F increases expression ISO Adra2a (Mus musculus) 6480464 bisphenol F results in increased expression of ADRA2A mRNA CTD PMID:30951980 brimonidine tartrate multiple interactions ISO Adra2a (Mus musculus) 6480464 Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein CTD PMID:12598592 brimonidine tartrate multiple interactions EXP 6480464 Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein CTD PMID:12208771 and PMID:8397342 brimonidine tartrate multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Brimonidine Tartrate inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein] more ... CTD PMID:10742289 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of ADRA2A mRNA CTD PMID:19167457 calcium atom multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [Epinephrine binds to and results in increased activity of ADRA2A protein] which results in increased abundance of Calcium and [Norepinephrine binds to and results in increased activity of ADRA2A protein] which results in increased abundance of Calcium CTD PMID:20030735 calcium(0) multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [Epinephrine binds to and results in increased activity of ADRA2A protein] which results in increased abundance of Calcium and [Norepinephrine binds to and results in increased activity of ADRA2A protein] which results in increased abundance of Calcium CTD PMID:20030735 capsaicin decreases response to substance ISO Adra2a (Mus musculus) 6480464 ADRA2A results in decreased susceptibility to Capsaicin CTD PMID:15220790 carbamazepine affects expression ISO ADRA2A (Homo sapiens) 6480464 Carbamazepine affects the expression of ADRA2A mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Adra2a (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:27106021 carbon nanotube affects expression ISO Adra2a (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of ADRA2A mRNA CTD PMID:23845593 and PMID:25554681 CGP 52608 multiple interactions ISO ADRA2A (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to ADRA2A gene] CTD PMID:28238834 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of ADRA2A mRNA CTD PMID:18812211 chlorpyrifos increases expression ISO Adra2a (Mus musculus) 6480464 Chlorpyrifos results in increased expression of ADRA2A mRNA CTD PMID:37019170 chlorpyrifos affects expression EXP 6480464 Chlorpyrifos affects the expression of ADRA2A mRNA CTD PMID:17452286 choline multiple interactions ISO Adra2a (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADRA2A gene CTD PMID:20938992 clonidine multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Clonidine binds to and results in increased activity of ADRA2A protein CTD PMID:10217548 clonidine multiple interactions EXP 6480464 [5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4 more ... CTD PMID:16595736 and PMID:17934014 clonidine multiple interactions ISO Adra2a (Mus musculus) 6480464 Clonidine binds to and results in increased activity of ADRA2A protein CTD PMID:12560108 and PMID:12598592 clonidine (amino form) multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Clonidine binds to and results in increased activity of ADRA2A protein CTD PMID:10217548 clonidine (amino form) multiple interactions EXP 6480464 [5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4 more ... CTD PMID:16595736 and PMID:17934014 clonidine (amino form) multiple interactions ISO Adra2a (Mus musculus) 6480464 Clonidine binds to and results in increased activity of ADRA2A protein CTD PMID:12560108 and PMID:12598592 clonidine (imino form) multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Clonidine binds to and results in increased activity of ADRA2A protein CTD PMID:10217548 clonidine (imino form) multiple interactions EXP 6480464 [5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo(4 more ... CTD PMID:16595736 and PMID:17934014 clonidine (imino form) multiple interactions ISO Adra2a (Mus musculus) 6480464 Clonidine binds to and results in increased activity of ADRA2A protein CTD PMID:12560108 and PMID:12598592 coumestrol multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA and ESR2 protein affects the reaction [[Coumestrol co-treated with ESR1 protein] results in increased expression of ADRA2A mRNA] CTD PMID:18310284 crocidolite asbestos affects expression ISO ADRA2A (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of ADRA2A mRNA CTD PMID:17331233 crocidolite asbestos decreases expression ISO Adra2a (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of ADRA2A mRNA CTD PMID:19446018 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ADRA2A mRNA CTD PMID:26577399 cyanazine affects binding EXP 6480464 cyanazine binds to ADRA2A protein CTD PMID:11071396 cyanazine affects activity EXP 6480464 cyanazine affects the activity of ADRA2A protein CTD PMID:11071396 cyclosporin A decreases methylation ISO ADRA2A (Homo sapiens) 6480464 Cyclosporine results in decreased methylation of ADRA2A promoter CTD PMID:27989131 dexamethasone multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADRA2A mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADRA2A mRNA CTD PMID:28628672 dexmedetomidine multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Dexmedetomidine binds to and results in increased activity of ADRA2A protein and Dexmedetomidine inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein] CTD PMID:10742289 and PMID:15627480 dextran sulfate multiple interactions ISO Adra2a (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADRA2A mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO ADRA2A (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of ADRA2A mRNA CTD PMID:26705709 diazinon increases expression EXP 6480464 Diazinon results in increased expression of ADRA2A mRNA CTD PMID:17452286 dobutamine multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Dobutamine binds to and results in increased activity of ADRA2A protein CTD PMID:16024912 dopamine affects binding ISO Adra2a (Mus musculus) 6480464 Dopamine binds to ADRA2A protein CTD PMID:10336518 dorsomorphin multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxazosin multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Doxazosin inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein] CTD PMID:10742289 doxazosin decreases expression ISO ADRA2A (Homo sapiens) 6480464 Doxazosin results in decreased expression of ADRA2A protein CTD PMID:10694191 doxazosin increases activity ISO ADRA2A (Homo sapiens) 6480464 Doxazosin results in increased activity of ADRA2A protein CTD PMID:10694191 entinostat increases expression ISO ADRA2A (Homo sapiens) 6480464 entinostat results in increased expression of ADRA2A mRNA CTD PMID:26272509 entinostat multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADRA2A mRNA CTD PMID:27188386 fipronil increases expression EXP 6480464 fipronil results in increased expression of ADRA2A mRNA CTD PMID:31881178 folic acid multiple interactions ISO Adra2a (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of ADRA2A mRNA CTD PMID:24915197 idazoxan multiple interactions EXP 6480464 [Idazoxan binds to and results in decreased activity of ADRA2A protein] which results in decreased susceptibility to amitraz CTD PMID:10582558 indapamide increases expression ISO ADRA2A (Homo sapiens) 6480464 Indapamide results in increased expression of ADRA2A protein CTD PMID:2829625 indometacin multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ADRA2A mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of ADRA2A mRNA CTD PMID:28628672 inulin multiple interactions ISO Adra2a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADRA2A mRNA CTD PMID:36331819 isotretinoin increases expression ISO ADRA2A (Homo sapiens) 6480464 Isotretinoin results in increased expression of ADRA2A mRNA CTD PMID:20436886 L-methionine multiple interactions ISO Adra2a (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ADRA2A gene CTD PMID:20938992 lead(0) affects expression ISO ADRA2A (Homo sapiens) 6480464 Lead affects the expression of ADRA2A mRNA CTD PMID:28903495 malathion increases expression ISO ADRA2A (Homo sapiens) 6480464 Malathion results in increased expression of ADRA2A mRNA CTD PMID:37047231 medetomidine multiple interactions ISO Adra2a (Mus musculus) 6480464 Medetomidine binds to and results in increased activity of ADRA2A protein CTD PMID:12598592 medetomidine affects response to substance ISO Adra2a (Mus musculus) 6480464 ADRA2A protein affects the susceptibility to Medetomidine CTD PMID:20083574 methylisothiazolinone increases expression ISO ADRA2A (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of ADRA2A mRNA CTD PMID:31629900 morphine increases expression EXP 401976538 morphine increases expression of Adra2a mRNA in cerebral cortex RGD Moxonidine multiple interactions ISO ADRA2A (Homo sapiens) 6480464 moxonidine binds to and results in increased activity of ADRA2A protein CTD PMID:10217548 naloxone multiple interactions EXP 401976538 naloxone co-treated with morphine increases expression of Adra2a mRNA in cerebral cortex RGD nickel atom increases expression EXP 6480464 Nickel results in increased expression of ADRA2A mRNA CTD PMID:18812211 niclosamide decreases expression ISO ADRA2A (Homo sapiens) 6480464 Niclosamide results in decreased expression of ADRA2A mRNA CTD PMID:36318118 oxcarbazepine multiple interactions EXP 6480464 [BRL 44408 binds to and results in decreased activity of ADRA2A protein] which results in decreased susceptibility to oxcarbazepine CTD PMID:17959985 oxymetazoline multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Oxymetazoline inhibits the reaction [ADRA2A protein binds to 2-methoxyidazoxan] CTD PMID:20030735 oxymetazoline affects binding ISO ADRA2A (Homo sapiens) 6480464 Oxymetazoline binds to ADRA2A protein CTD PMID:20030735 ozone decreases expression ISO Adra2a (Mus musculus) 6480464 Ozone results in decreased expression of ADRA2A mRNA CTD PMID:33026818 panobinostat multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADRA2A mRNA CTD PMID:27188386 paracetamol affects expression ISO Adra2a (Mus musculus) 6480464 Acetaminophen affects the expression of ADRA2A mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ADRA2A mRNA CTD PMID:33387578 paracetamol decreases expression ISO ADRA2A (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ADRA2A mRNA CTD PMID:22230336 perfluorooctane-1-sulfonic acid multiple interactions ISO Adra2a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ADRA2A mRNA CTD PMID:36331819 phenobarbital affects expression ISO Adra2a (Mus musculus) 6480464 Phenobarbital affects the expression of ADRA2A mRNA CTD PMID:19136022 phentolamine multiple interactions EXP 6480464 Phentolamine binds to and results in decreased activity of ADRA2A protein CTD PMID:8397342 phenylephrine multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein] more ... CTD PMID:10742289 phenylmercury acetate multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADRA2A mRNA CTD PMID:27188386 phenylpropanolamine affects binding ISO ADRA2A (Homo sapiens) 6480464 Phenylpropanolamine binds to ADRA2A protein CTD PMID:20217639 phorbol 13-acetate 12-myristate multiple interactions ISO Adra2a (Mus musculus) 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in increased expression of ADRA2A mRNA CTD PMID:23519560 picrotoxin increases expression EXP 6480464 Picrotoxin results in increased expression of ADRA2A mRNA CTD PMID:15170462 pirinixic acid multiple interactions ISO Adra2a (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ADRA2A mRNA more ... CTD PMID:17950772 more ... pirinixic acid increases expression ISO Adra2a (Mus musculus) 6480464 pirinixic acid results in increased expression of ADRA2A mRNA CTD PMID:18301758 and PMID:20813756 pirinixic acid decreases expression ISO Adra2a (Mus musculus) 6480464 pirinixic acid results in decreased expression of ADRA2A mRNA CTD PMID:17950772 pirinixic acid affects expression ISO Adra2a (Mus musculus) 6480464 pirinixic acid affects the expression of ADRA2A mRNA CTD PMID:19136022 potassium atom multiple interactions EXP 6480464 [BRL 44408 binds to and results in decreased activity of ADRA2A protein] inhibits the reaction [Xylazine inhibits the reaction [Potassium results in increased secretion of Norepinephrine]] CTD PMID:11312645 potassium dichromate increases expression ISO Adra2a (Mus musculus) 6480464 Potassium Dichromate results in increased expression of ADRA2A mRNA CTD PMID:23608068 prazosin multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Prazosin inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein] and Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]] CTD PMID:10742289 prazosin multiple interactions EXP 6480464 Prazosin binds to and results in decreased activity of ADRA2A protein CTD PMID:8397342 pregabalin decreases expression ISO Adra2a (Mus musculus) 6480464 Pregabalin results in decreased expression of ADRA2A mRNA CTD PMID:22489711 progesterone increases expression ISO Adra2a (Mus musculus) 6480464 Progesterone results in increased expression of ADRA2A mRNA CTD PMID:15713686 reserpine increases expression EXP 6480464 Reserpine results in increased expression of ADRA2A mRNA CTD PMID:11264240 Rilmenidine affects binding ISO ADRA2A (Homo sapiens) 6480464 rilmenidine binds to ADRA2A protein CTD PMID:10217548 SB 431542 multiple interactions ISO ADRA2A (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO ADRA2A (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of ADRA2A mRNA CTD PMID:25895662 synephrine affects binding ISO ADRA2A (Homo sapiens) 6480464 Synephrine binds to ADRA2A protein CTD PMID:20217639 Talipexole dihydrochloride multiple interactions ISO ADRA2A (Homo sapiens) 6480464 talipexole inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein] CTD PMID:10742289 tamoxifen increases expression ISO Adra2a (Mus musculus) 6480464 Tamoxifen results in increased expression of ADRA2A mRNA CTD PMID:25123088 testosterone increases expression ISO Adra2a (Mus musculus) 6480464 Testosterone results in increased expression of ADRA2A mRNA CTD PMID:15713686 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ADRA2A mRNA CTD PMID:16644059 thapsigargin multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Thapsigargin inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein] CTD PMID:10742289 titanium dioxide decreases expression ISO Adra2a (Mus musculus) 6480464 titanium dioxide results in decreased expression of ADRA2A mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO Adra2a (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADRA2A mRNA CTD PMID:29950665 topiramate increases expression ISO Adra2a (Mus musculus) 6480464 topiramate results in increased expression of ADRA2A mRNA CTD PMID:22489711 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ADRA2A mRNA CTD PMID:33387578 trichostatin A increases expression ISO ADRA2A (Homo sapiens) 6480464 trichostatin A results in increased expression of ADRA2A mRNA CTD PMID:24935251 triclosan increases expression ISO ADRA2A (Homo sapiens) 6480464 Triclosan results in increased expression of ADRA2A mRNA CTD PMID:30510588 triptonide increases expression ISO Adra2a (Mus musculus) 6480464 triptonide results in increased expression of ADRA2A mRNA CTD PMID:33045310 U-73122 multiple interactions ISO ADRA2A (Homo sapiens) 6480464 1-(6-((3-methoxyestra-1 more ... CTD PMID:10742289 valproic acid affects expression ISO ADRA2A (Homo sapiens) 6480464 Valproic Acid affects the expression of ADRA2A mRNA CTD PMID:25979313 valproic acid increases expression ISO ADRA2A (Homo sapiens) 6480464 Valproic Acid results in increased expression of ADRA2A mRNA CTD PMID:24383497 and PMID:24935251 valproic acid increases methylation ISO ADRA2A (Homo sapiens) 6480464 Valproic Acid results in increased methylation of ADRA2A gene CTD PMID:29154799 xylazine multiple interactions EXP 6480464 [BRL 44408 binds to and results in decreased activity of ADRA2A protein] inhibits the reaction [Xylazine inhibits the reaction [Potassium results in increased secretion of Norepinephrine]] CTD PMID:11312645 Xylometazoline affects binding ISO ADRA2A (Homo sapiens) 6480464 xylometazoline binds to ADRA2A protein CTD PMID:20030735 Xylometazoline multiple interactions ISO ADRA2A (Homo sapiens) 6480464 xylometazoline inhibits the reaction [ADRA2A protein binds to 2-methoxyidazoxan] CTD PMID:20030735 yohimbine multiple interactions ISO ADRA2A (Homo sapiens) 6480464 Yohimbine inhibits the reaction [Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]] and Yohimbine inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein] CTD PMID:10742289 yohimbine multiple interactions ISO Adra2a (Mus musculus) 6480464 Yohimbine binds to and results in decreased activity of ADRA2A protein CTD PMID:17666864 yohimbine multiple interactions EXP 6480464 Yohimbine binds to and results in decreased activity of ADRA2A protein CTD PMID:8397342